What Matters to People When Choosing to Take Part in Clinical Research How to Use This Resource We conducted a literature review, utilizing a variety of resources that highlight different preferences, motivations, and perceptions. We have displayed the results below. By clicking on the questions, you can see the way Read more…
I Am Included I Am Included | Tigerlily Recommendations for Diverse Clinical Trial Site Leaders: An actionable framework for inclusive clinical trials. View Here
Expectation Setting for your Patient Advocacy Group (PAG)-Industry Partnership Expectation Setting for your Patient Advocacy Group (PAG)-Industry Partnership Are you a Patient Advocacy Group (PAG) forming a new partnership with a pharmaceutical company or biotech? Are you a sponsor initiating a collaboration with a Patient Advocacy Group (PAG) and looking Read more…
Example of Collaboration Opportunities Example of Collaboration Opportunities | Accelerated Cure Project Example of Collaboration Opportunities from Accelerated Cure Project View here
A Collaboration Between PAG/Industry On Target Product Profile (TPP) A Collaboration Between PAG/Industry On Target Product Profile (TPP) PALADIN’s Interactive Guide to help the pharmaceutical industry and patient advocacy groups (PAGs) collaborate on the Target Product Profile (TPP), a critical planning tool used by industry to facilitate communication with the Read more…
Principles for Compensating Patients for Patient Engagement Activities Principles for Compensating Patients for Patient Engagement Activities | The National Health Council A set of best practices from the National Health Council on providing compensation to patients. View Here
Principles on Contracting Between Patient Advocates and Pharmaceutical Companies Principles on Contracting Between Patient Advocates and Pharmaceutical Companies | The National Health Council A set of rationale, examples, and guiding principles for legal agreements between pharmaceutical companies and patients from the National Health Council. View Here
Target Product Profile (TPP) Playbook Target Product Profile (TPP) Playbook | Becca Kirby – 1Day Sooner A guide to designing a formal process for developing TPP, aimed towards anyone looking to scale their TPP process. View Here
Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap | Stegemann et al Read more…
Patient Engagement Book of Good Practices Patient Engagement Book of Good Practices | PFMD “An outline of patient engagment initiatives that are considered good practices. “”Patient Engagement Book of Good Practices”” by PFMD (https://patientfocusedmedicine.org/) is licensed under CC BY-NC-SA 4.0. (https://creativecommons.org/licenses/by-nc-sa/4.0/)” View Here
Example Target Product Profile Example Target Product Profile | NIH An example of a target product profile for an ischemic stroke revascularization product. View Here
Target Product Profile Questionnaire Target Product Profile Questionnaire | NIH A collection of questions that companies can use to inform the Target Product Profile (TPP). The end of the document also includes links to four example TPP documents for small molecule, biologic, vaccine, and gene therapy. View Here
Constructing a Target Product Profile – Industry’s Perspective Constructing a Target Product Profile – Industry’s Perspective | BIOCurate A fact sheet on target product profile, including a template. View Here
Building Clinical Trial and Health Research Access for People of Color via Community Health Centers (CHCs) Toolkit Building Clinical Trial and Health Research Access for People of Color via Community Health Centers (CHCs) Toolkit | Neighborhood Health Care and Altura This toolkit is a supplement to the white paper examining Read more…
Patient Experience: Gratitude Toolkit Patient Experience: Gratitude Toolkit | TransCelerate TransCelerate, in partnership with patients/care partners, sites, and industry sponsors, developed the Gratitude Toolkit (GRAT), a set of deliverables that sponsors, with their site partners, can leverage to acknowledge and show appreciation to clinical trial participants. The GRAT streamlines options Read more…
Solution Implementation Experiences Solution Implementation Experiences | TransCelerate TransCelerate has received 100+ experiences reported from organizations that have implemented and benefited from TransCelerate solutions. Anyone can submit an experience or search the library to see how the solutions can benefit their organizations and help accelerate answers for patients. View Here
Study Participant Feedback Questionnaire Toolkit Study Participant Feedback Questionnaire Toolkit | TransCelerate The Study Participant Feedback Questionnaire (SPFQ) is a survey provided to study participants at the beginning, middle and end of a clinical study. View Here
About TransCelerate About TransCelerate | TransCelerate TransCelerate BioPharma Inc. is a non-profit organization with a mission to collaborate across the global biopharmaceutical research and development community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high-quality delivery of new medicines. View Here
Patient Protocol Engagement Toolkit (P-PET) Patient Protocol Engagement Toolkit (P-PET) | TransCelerate Transcelerate’s Patient Protocol Engagement Toolkit (P-PET) is a comprehensive set of materials that sponsors and other stakeholders can use to engage patients and caregivers during protocol development. The goal of this engagement is to improve patient experience and Read more…
Personalized Clinical Trials Framework Personalized Clinical Trials Framework | TransCelerate TransCelerate’s interactive Personalized Clinical Trials Framework is a set of practical considerations to support the R&D ecosystem (i.e., sponsors, sites, third parties, and other clinical trial stakeholders) with understanding and evaluating options that enable a more personalized experience for clinical Read more…